Apixaban in glomerulonephritis with nephrotic syndrome: thromboprophylaxis and pleiotropic effects in a prospective cohort study

Aim: to assess the efficacy and safety of apixaban in preventing thromboembolic complications in patients with nephrotic syndrome (NS) due to primary glomerulonephritis, and to investigate its potential anti-inflammatory and antifibrotic effects. Materials and methods. A prospective longitudina...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	I. S. Mykhaloiko, R. I. Yatsyshyn, N. V. Cherniuk, V. Ya. Kaminskyi, M. Ya. Humeniuk
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Zaporizhzhia State Medical and Pharmaceutical University 2025-09-01
Sarja:	Сучасні медичні технології
Aiheet:	apixaban nephrotic syndrome glomerulonephritis thromboprophylaxis inflammation fibrosis anticoagulation biomarkers
Linkit:	https://medtech.mphu.edu.ua/article/view/335542/328343
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!